NASDAQ:STAB
Statera Biopharma, Inc. Stock News
$0.0006
+0 (+0%)
At Close: May 31, 2024
Statera Biopharma, Inc. to Participate in the A.G.P. Biotech and Specialty Pharma Conference
07:33am, Wednesday, 06'th Oct 2021
FORT COLLINS, Colo., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (Nasdaq: STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restor
Statera Biopharma Announces CEO Mike Handley to Speak During Virtual B & T Cell-Mediated Autoimmune Disease Drug Development Summit
07:32am, Tuesday, 05'th Oct 2021
FORT COLLINS, Colo., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (Nasdaq: STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restor
Statera Biopharma, Inc. to Participate in the Cantor Virtual Global Healthcare Conference
07:31am, Tuesday, 21'st Sep 2021
FORT COLLINS, Colo., Sept. 21, 2021 /PRNewswire/ -- Statera Biopharma, Inc. (Nasdaq: STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restora
Statera BioPharma, Inc. to Ring Nasdaq Stock Market Closing Bell
01:08pm, Thursday, 09'th Sep 2021
FORT COLLINS, Colo., Sept. 2, 2021 /PRNewswire/ -- Statera BioPharma, Inc. (Nasdaq: STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restorati
Statera BioPharma: The Ticker Formerly Known as CBLI
08:06am, Tuesday, 07'th Sep 2021
On September 1, 2021, Cytocom officially became listed as Statera BioPharma, Inc. (NASDAQ: STAB), as it updated its ticker symbol from CLBI to STAB within the Nasdaq markets. This change in name com
Statera BioPharma, Inc. Provides Update on Integration of ImQuest
09:20am, Wednesday, 01'st Sep 2021
FORT COLLINS, Colo., Sept. 1, 2021 /PRNewswire/ -- Statera BioPharma (NASDAQ: STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration a
